News

Cutting federal funds for mRNA vaccine leaves the US vulnerable, experts say

This week, President Donald Trump called Operation Warp Speed, a public-private federal program that helped speed up the ...
PharmExec52m

GSK Gains $370 Million Upfront, Reduced Royalties in CureVac mRNA Patent Settlement Agreement with Pfizer, BioNTech

The settlement ends US mRNA patent disputes involving COVID-19 and influenza vaccines, while positioning GSK for additional ...
CIDRAP21h

Study: mRNA COVID vaccines cost-effective for US seniors, and under some scenarios, younger adults

Vaccination was cost saving for participants aged 65 years and older. In phase 2 analyses, an additional dose was ...

CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

UPenn, where mRNA vaccine tech was pioneered, will not lose funding as feds cut $500M in mRNA grants

There have been no changes to the licensing and royalty agreements related to mRNA research that have netted the university ...
McKnight's Long-Term Care News1d

HHS makes mRNA vaccine project cuts as booster fatigue marks changing public attitude toward shots

On Tuesday, the US Department of Health and Human Services disclosed the end of funding for 22 mRNA vaccine projects — a ...

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...